🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims at elucidating the mechanism of action of ianalumab in sali...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-07-27
Trial ID
NCT05124925
Treatments Being Tested
This study was designed to evaluate the safety, tolerability, pharmacokinet...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-05-23
Trial ID
NCT02149420
The purpose of this study is to assess the safety, tolerability, pharmacoki...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2022-01-24
Trial ID
NCT04903197
Treatments Being Tested
This study investigated the safety and tolerability of VAY736 administered ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-12-20
Trial ID
NCT02675803
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of iana...
Status
Recruiting
Location
Sun Valley Arthritis Center Ltd
Start Date
2026-07-16
Trial ID
NCT07621809
The purpose of this study is to investigate the tolerability of ianalumab (...
Status
Recruiting
Location
Highlands Oncology Group
Start Date
2026-08-04
Trial ID
NCT07421167
Treatments Being Tested
The purpose of this registration is to list Managed Access Programs (MAPs) ...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT07244289
Treatments Being Tested
This study consists of three consecutive parts. Part 1 in primary Sjögren's...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02495129
Treatments Being Tested
The main purpose of this study is to assess preliminary efficacy and safety...
Status
Active Not Recruiting
Location
Olympian Clinical Research
Start Date
2019-02-27
Trial ID
NCT03827798
This was a randomized, partially blinded, placebo-controlled, non-confirmat...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-12-20
Trial ID
NCT02038049